Ninety percent of the adverse outcomes occur in 10% of patients: can we identify the populations at high risk of developing peritoneal metastases after curative surgery for colorectal cancer?

Update on clinical trials in colorectal cancer peritoneal metastasis

(2017) Amandine Pinto et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer

(2016) J. Segelman et al.   Colorectal Disease

The effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as an adjuvant in patients with resectable pancreatic cancer

(2016) Antonios-Apostolos Tentes et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

(2016) Ramy Girshally et al.   World Journal of Surgical Oncology

Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy?

(2016) C. Honoré et al.   Journal of Visceral Surgery

Routine second-look after surgical treatment of colonic peritoneal carcinomatosis

(2015) J.B. Delhorme et al.   Journal of Visceral Surgery

Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer

(2014) J. Segelman et al.   Colorectal Disease

Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases

(2014) P. Sammartino et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: Results of a multicentre retrospective study

(2013) C. Honoré et al.   EJSO

Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis

(2013) Y.L.B. Klaver et al.   EJSO

Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: Results of EVOCAPE 2 multicentre prospective study

(2013) E. Cotte et al.   EJSO

HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?

(2012) D. Hompes et al.   ANNALS OF ONCOLOGY

Adjuvant Chemotherapy After Resection of Colorectal Liver Metastases in Patients at High Risk of Hepatic Recurrence

(2012) Diane Goéré et al.   ANNALS OF SURGERY

Definition of Patients Presenting a High Risk of Developing Peritoneal Carcinomatosis After Curative Surgery for Colorectal Cancer: A Systematic Review

(2012) Charles Honoré et al.   ANNALS OF SURGICAL ONCOLOGY

Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis

(2011) D Elias et al.   ANNALS OF SURGERY

Results of Two Bi-Institutional Prospective Studies Using Intraperitoneal Oxaliplatin With or Without Irinotecan During HIPEC After Cytoreductive Surgery for Colorectal Carcinomatosis

(2011) François Quenet et al.   ANNALS OF SURGERY

Incidence, Patterns of Failure, and Prognosis of Perforated Colorectal Cancers in a Well-Defined Population

(2011) Nicolas Cheynel et al.   DISEASES OF THE COLON & RECTUM

Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis

(2010) Kenji Matsuda et al.   SURGERY

Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases

(2010) Robert T Ripley et al.   Trials

Revised Tumor and Node Categorization for Rectal Cancer Based on Surveillance, Epidemiology, and End Results and Rectal Pooled Analysis Outcomes

(2009) Leonard L. Gunderson et al.   JOURNAL OF CLINICAL ONCOLOGY

Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study

(2009) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery

(2009) Yutaka Yonemura et al.   JOURNAL OF SURGICAL ONCOLOGY

8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer

(2008) Vic J. Verwaal et al.   ANNALS OF SURGICAL ONCOLOGY

The impact of spontaneous tumour perforation on outcome following colon cancer surgery

(2008) A. S. Abdelrazeq et al.   Colorectal Disease